ArticlePathogens & immunity2016

Rosuvastatin Decreases Intestinal Fatty Acid Binding Protein (I-FABP), but Does Not Alter Zonulin or Lipopolysaccharide Binding Protein (LBP) Levels, in HIV-Infected Subjects on Antiretroviral Therapy.

Nicholas T Funderburg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.